dm+d

Unassigned

New Medicines

Cytomegalovirus (CMV) infections - prevention

Information

Vaccine
Moderna Therapeutics
Moderna Therapeutics

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Immunostimulant mRNA vaccine
CMV is the most common infection passed from mother to unborn baby. The majority of babies born with congenital CMV will not have any symptoms at birth and will not suffer long term problems. However, two to three babies are affected by the CMV virus every day in the UK (~1000 babies/year) [3].
Cytomegalovirus (CMV) infections - prevention
Intramuscular